Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.
Takuma MatsumuraJiro TeradaTaku KinoshitaYoriko SakuraiMisuzu YahabaKenji TsushimaSeiichiro SakaoKengo NagashimaToshinori OzakiYoshio KobayashiTakaki HiwasaKoichiro TatsumiPublished in: PloS one (2018)
Elevated NBL1-Ab levels may be associated with the prevalence of CAD in patients with OSA, which needs to be confirmed further.
Keyphrases
- obstructive sleep apnea
- coronary artery disease
- positive airway pressure
- cardiovascular events
- percutaneous coronary intervention
- systemic lupus erythematosus
- risk factors
- coronary artery bypass grafting
- sleep apnea
- aortic stenosis
- heart failure
- type diabetes
- cardiovascular disease
- atrial fibrillation
- aortic valve